176
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Single Agent Epirubicin in Squamous Cell Cervical Cancer: A phase II trial

, , , , , , , , , & show all
Pages 325-327 | Received 10 Jan 1990, Accepted 08 Jun 1990, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Aleksandar Evangelatov, Ralica Skrobanska, Nikola Mladenov, Milena Petkova, Georgi Yordanov & Roumen Pankov. (2016) Epirubicin loading in poly(butyl cyanoacrylate) nanoparticles manifests via altered intracellular localization and cellular response in cervical carcinoma (HeLa) cells. Drug Delivery 23:7, pages 2235-2244.
Read now

Articles from other publishers (7)

Perry W. Grigsby, Christine M. Gan, Todd D. Tillmanns & Giuseppe Del Priore. (2014) In Vitro Chemoresponse Analysis of Cervical Cancer Patient Specimens. International Journal of Gynecological Cancer 24:9, pages 1665-1674.
Crossref
Alfonso Dueñas-González, Lucely Cetina, Jaime Coronel & Déborah Martínez-Baños. (2010) Pharmacotherapy Options for Locally Advanced and Advanced Cervical Cancer. Drugs 70:4, pages 403-432.
Crossref
Myrna Candelaria, Alicia Garcia-Arias, Lucely Cetina & Alfonso Dueñas-Gonzalez. (2006) Radiosensitizers in cervical cancer. Cisplatin and beyond. Radiation Oncology 1:1.
Crossref
Peter G. Rose, John A. Blessing, Shashikant Lele & Ovadia Abulafia. (2006) Evaluation of pegylated liposomal doxorubicin (Doxil) as second-line chemotherapy of squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group. Gynecologic Oncology 102:2, pages 210-213.
Crossref
M.E.L. van der Burg, G. Bolis, J.M. Bakker, D. Curran, T. Sahmoud & J.B. Vermerken. (1997) Phase II study of weekly 4′-epidoxorubicin in patients with metastatic adenocarcinoma of the cervix: an EORTC gynaecological cancer cooperative group study. European Journal of Cancer 33:9, pages 1513-1515.
Crossref
E. E. Holdener, G. Massimini, S. Lippman, W. Bollag & A. Man. 1994. Immuntherapie in der gynäkologischen Onkologie. Immuntherapie in der gynäkologischen Onkologie 75 92 .
M.E.L. van der Burg, S. Monfardini, J.P. Guastalla, C. de Oliveira, J. Renard & J.B. Vermorken. (1993) Phase II study of weekly 4′-epidoxorubicin in patients with metastatic squamous cell cancer of the cervix: An EORTC Gynaecological Cancer Cooperative Group Study. European Journal of Cancer 29:1, pages 147-148.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.